[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Kojo Elenitoba-Johnson<\/i><\/u><\/presenter>. Univ. of Pennsylvania School of Medicine, Philadelphia, PA","CSlideId":"","ControlKey":"0e74e7fb-9418-44c9-832d-f85afd771325","ControlNumber":"8653","DisclosureBlock":"","End":"4\/11\/2022 7:45:00 AM","HasWebcast":null,"Highlights":[],"Id":"18100","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Kojo Elenitoba-Johnson, Ph.D","PresenterKey":"69e31994-fb02-44ca-b679-c057a4f0f4eb","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Proteogenomics as a driver for discovery of novel mechanisms and therapeutic targets in lymphoma","SearchResultFooter":"","SearchResultHeader":"Apr 11 2022  7:00AM","SessionId":"669","SessionOnDemand":"False","SessionTitle":"Proteogenomics as a Driver for Discovery of Novel Mechanisms and Therapeutic Targets in Lymphoma","ShowChatLink":"false","Start":"4\/11\/2022 7:00:00 AM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Proteogenomics as a driver for discovery of novel mechanisms and therapeutic targets in lymphoma","Topics":null,"cSlideId":""}]